Article

The Hindu on 2021-01-18 11:00

Bharat Biotech clarifies on COVAXIN usage

Company releases fact sheet detailing possible adverse events and those who are eligible for the vaccine

Related news

Covaxin safe for kids: Bharat Biotech The Times of India
Uttarakhand , Mumbai , South Africa , Delhi , Haldwani (Kathgodam)
Bharat Biotech says COVID-19 vaccine Covaxin shows 81% interim efficacy The Hindu
The Hindu , India
Coronavirus | Covaxin trial participants could test positive, says Bharat Biotech The Hindu
The Hindu , Adar , Moscow , India , Bahrain
Coronavirus | After SII, Bharat Biotech seeks DCGI approval for Covaxin The Hindu
Brazil , Bahrain , United Kingdom , India , Pune
'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
Switzerland , Australia , Montreal , Vancouver , Toronto
Bharat Biotech terminates Covaxin pact with Brazil partners The Times of India
India , Brazil
Slowing down Covaxin output across plants: Bharat Biotech The Times of India
India
Death of Bhopal volunteer not due to Covaxin, says Bharat BioTech The Hindu
The Hindu , India , Bhopal
Coronavirus | 130 Covaxin trial volunteers may test positive, says Bharat Biotech The Hindu
The Hindu , Adar , Moscow , India , Bahrain
Coronavirus | Bharat Biotech to pay compensation if Covaxin vaccine causes side effects The Hindu
The Hindu , India , New Delhi
Coronavirus | Bharat Biotech to make 6 crore Covaxin doses by July The Hindu
Bangalore , Hyderabad , India , Mumbai , New Delhi
Coronavirus live updates | Bharat Biotech to make 6 crore Covaxin doses by July The Hindu
Austria , Germany , Hyderabad , Mumbai , Brazil
Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacy The Hindu
Pune , India
India’s Bharat Biotech says its Covaxin coronavirus vaccine is 81 per cent effective South China Morning Post
Cambodia , South Asia , Asia , India
No paracetamol, painkillers needed after Covaxin jab: Bharat Biotech The Hindu
Amid rising viral cases, Bharat Biotech working on H3N2 vaccine The Times of India
Saint Louis , India
Bharat Biotech yet to start supply of May order of Covaxin: Centre The Hindu
India , Brazil , The Hindu , Canada , Chennai
Coronavirus updates | 'Need complete data': DCGI puts SII, Bharat Biotech vaccine approval requests on hold The Hindu
Maharashtra , Bahrain , United Kingdom , India , Bangalore
Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada The Hindu
Hungary , Brazil , India , New Delhi , Canada
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech The Hindu
India